Department of Family Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Division of Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Cancer Res Treat. 2021 Jul;53(3):881-888. doi: 10.4143/crt.2020.1008. Epub 2020 Dec 22.
The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access.
Terminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death).
A total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, 'a little comfort' or 'much comfort') compared with the usual IV arm (21%) (p <0.001).
Routine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit.
本研究旨在探讨在临终关怀(HPC)病房入院时常规插入外周静脉置入中心导管(PICC)在安全性和疗效方面是否可行,以及与常规静脉(IV)通路相比是否能提高患者满意度。
将终末期癌症患者随机分配到两组:常规 PICC 通路组和常规 IV 通路组。主要终点是 IV 维持成功率,定义为功能 IV 维持直至预定时间(出院、转科或死亡)的比率。
共纳入 66 例终末期癌症患者并随机分配至研究组。其中,57 例患者(常规 PICC 组 29 例,常规 IV 组 28 例)纳入分析。在常规 PICC 组中,PICC 置管时间的平均值为 0.84 天(范围:0-3 天),27 例患者维持 PICC 功能直至预定时间。在常规 IV 组中,11 例患者维持外周 IV 通路直至预定时间,15 例患者行 PICC 置管。常规 PICC 组(27/29,93.1%)的 IV 维持成功率与常规 IV 组(26/28,92.8%)相似(p=0.958)。常规 PICC 组(97%,“稍有舒适”或“非常舒适”)患者在第 5 天的满意度优于常规 IV 组(21%)(p<0.001)。
在终末期癌症患者中,常规 PICC 置管在安全性和疗效方面与常规 IV 通路相当,但患者满意度更高。因此,在 HPC 病房入院时可考虑常规 PICC 置管。